VOR

Vor Biopharma Inc

NASDAQ: VOR · HEALTHCARE · BIOTECHNOLOGY

$22.30

-0.18% today

Updated 2026-09-11

Market cap

$1.48B

P/E ratio

0.14

P/S ratio

—

EPS (TTM)

$180.69

Dividend yield

—

52W range

$7 – $50

Volume

1.0M

Market cap

$1.48B

P/E ratio

0.14

P/S ratio

—

EPS (TTM)

$180.69

Dividend yield

—

52W range

$7 – $50

Volume

1.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

6.7

Valuation

2/9

Piotroski F-Score

Weak

-7.3

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target

$39.00

+74.89%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity -0.01x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -7.31 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-25.79M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	—
Net income	$-92.09M	$-117.86M	$-116.91M	$-695.98M	$-62.81M
EPS	—	—	—	—	$180.69
Free cash flow	$-93.61M	$-101.36M	$-99.89M	$-143.65M	$-25.79M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-07-07	ZACCARDELLI, DAVID	Buy	42,658	—
2026-06-11	RA, CAPITAL MANAGEMENT, L.P.	Buy	57,162	—
2026-06-11	NAMOUNI, FOUAD	Buy	56,549	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VOR	$1.48B	33	4.3	3.0	6.7	6.5	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	2.7	6.0	-88.93%	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-69.36%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-73.74%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	6.0	-16.10%	Buy

Smart narrative

Vor Biopharma Inc trades at $22.30. representing a P/E of 0.14x trailing earnings. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -7.31, it sits in the distress.

Frequently asked questions

What is Vor Biopharma Inc's stock price?

Vor Biopharma Inc (VOR) trades at $22.30, on a P/E of 0.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is Vor Biopharma Inc overvalued?

Vor Biopharma Inc carries a Smart Value Score of 33/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Vor Biopharma Inc (VOR)?

The 12-month analyst consensus target is $39.00, about 74.9% above the current $22.30. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Vor Biopharma Inc's Altman Z-Score is -7.31, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-125.40%

Beta1.72

50D MA$21.19

200D MA$15.64

Shares out0.06B

Float0.04B

Short ratio—

Avg volume1.0M

Performance

1 week+13.19%

1 month+5.88%

3 months+57.40%

YTD+66.67%

1 year—

3 years—

5 years—

Compare

VOR vs LLY →VOR vs JNJ →VOR vs ABBV →Stock screener →